chr3-185428815-C-A
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_004721.5(MAP3K13):c.234C>A(p.Asp78Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000489 in 1,614,100 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 12/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_004721.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
MAP3K13 | NM_004721.5 | c.234C>A | p.Asp78Glu | missense_variant | 2/14 | ENST00000265026.8 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
MAP3K13 | ENST00000265026.8 | c.234C>A | p.Asp78Glu | missense_variant | 2/14 | 1 | NM_004721.5 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000296 AC: 45AN: 152116Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000638 AC: 16AN: 250964Hom.: 0 AF XY: 0.0000516 AC XY: 7AN XY: 135644
GnomAD4 exome AF: 0.0000233 AC: 34AN: 1461866Hom.: 0 Cov.: 31 AF XY: 0.0000220 AC XY: 16AN XY: 727236
GnomAD4 genome AF: 0.000296 AC: 45AN: 152234Hom.: 0 Cov.: 32 AF XY: 0.000309 AC XY: 23AN XY: 74428
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Apr 07, 2022 | The c.234C>A (p.D78E) alteration is located in exon 2 (coding exon 1) of the MAP3K13 gene. This alteration results from a C to A substitution at nucleotide position 234, causing the aspartic acid (D) at amino acid position 78 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at